Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-02
2009-08-25
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S333000, C544S333000, C546S257000
Reexamination Certificate
active
07579353
ABSTRACT:
4-pyridone derivatives of Formula (I) and pharmaceutically acceptable derivatives thereof, processes for their preparation, pharmaceutical formulations thereof and their use in chemotherapy of certain parasitic infections such as malaria, are provided.
REFERENCES:
patent: 0 499 416 (1992-08-01), None
patent: WO 91/13873 (1991-09-01), None
Bradbury, Robert H., et al., “New nonpeptide angiotensin II receptor antagonists. 3. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy) pyridine derivatives.”Journal of Medicinal Chemistry36(9), 1245-54.
Bueno Calderon Jose Maria
Fiandor Roman Jose Maria
Mallo Rubio Araceli
Davis Zinna N
Glaxo Group Limited
Lemanowicz John
Willis Reid S.
LandOfFree
Pyridinone derivatives against malaria does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridinone derivatives against malaria, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridinone derivatives against malaria will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4099760